Ibrahim-Zada I - Search Results

1

Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis.

Subramanian S, Goldstein DP, Parlea L, Thabane L, Ezzat S, Ibrahim-Zada I, Straus S, Brierley JD, Tsang RW, Gafni A, Rotstein L, Sawka AM. Subramanian S, et al. Thyroid. 2007 Dec;17(12):1277-88. doi: 10.1089/thy.2007.0171. Thyroid. 2007. PMID: 18020916 Review.

2

Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.

Sawka AM, Thabane L, Parlea L, Ibrahim-Zada I, Tsang RW, Brierley JD, Straus S, Ezzat S, Goldstein DP. Sawka AM, et al. Thyroid. 2009 May;19(5):451-7. doi: 10.1089/thy.2008.0392. Thyroid. 2009. PMID: 19281429 Review.

3

Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review.

Sawka AM, Ibrahim-Zada I, Galacgac P, Tsang RW, Brierley JD, Ezzat S, Goldstein DP. Sawka AM, et al. Thyroid. 2010 Oct;20(10):1129-38. doi: 10.1089/thy.2010.0055. Thyroid. 2010. PMID: 20860420 Free PMC article. Review.

4

Discovery of genetic profiles impacting response to chemotherapy: application to gemcitabine.

Jarjanazi H, Kiefer J, Savas S, Briollais L, Tuzmen S, Pabalan N, Ibrahim-Zada I, Mousses S, Ozcelik H. Jarjanazi H, et al. Hum Mutat. 2008 Apr;29(4):461-7. doi: 10.1002/humu.20732. Hum Mutat. 2008. PMID: 18330920

5

NCI60 cancer cell line panel data and RNAi analysis help identify EAF2 as a modulator of simvastatin and lovastatin response in HCT-116 cells.

Savas S, Azorsa DO, Jarjanazi H, Ibrahim-Zada I, Gonzales IM, Arora S, Henderson MC, Choi YH, Briollais L, Ozcelik H, Tuzmen S. Savas S, et al. PLoS One. 2011 Apr 4;6(4):e18306. doi: 10.1371/journal.pone.0018306. PLoS One. 2011. PMID: 21483694 Free PMC article.

6

Bioinformatic analyses identifies novel protein-coding pharmacogenomic markers associated with paclitaxel sensitivity in NCI60 cancer cell lines.

Eng L, Ibrahim-zada I, Jarjanazi H, Savas S, Meschian M, Pritchard KI, Ozcelik H. Eng L, et al. BMC Med Genomics. 2011 Feb 11;4:18. doi: 10.1186/1755-8794-4-18. BMC Med Genomics. 2011. PMID: 21314952 Free PMC article.

7

Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR).

Tram E, Ibrahim-Zada I, Briollais L, Knight JA, Andrulis IL, Ozcelik H. Tram E, et al. Breast Cancer Res. 2011 Aug 11;13(4):R77. doi: 10.1186/bcr2926. Breast Cancer Res. 2011. PMID: 21835029 Free PMC article.

8

A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistance.

Savas S, Briollais L, Ibrahim-zada I, Jarjanazi H, Choi YH, Musquera M, Fleshner N, Venkateswaran V, Ozcelik H. Savas S, et al. PLoS One. 2010 Sep 7;5(9):e12601. doi: 10.1371/journal.pone.0012601. PLoS One. 2010. PMID: 20830292 Free PMC article.

9

An assessment of perioperative outcomes for open, laparoscopic, and robot-assisted pancreaticoduodenectomy in New York State.

Wach MM, Myneni AA, Miller L, Boccardo J, Ibrahim-Zada I, Schwaitzberg SS, Noyes K, Gajdos C. Wach MM, et al. Among authors: ibrahim zada i. J Surg Oncol. 2022 Dec;126(8):1434-1441. doi: 10.1002/jso.27075. Epub 2022 Aug 20. J Surg Oncol. 2022. PMID: 35986891

10

Intrathoracic transmural esophageal perforation (Boerhaave's syndrome): Challenges in management of the delayed presentation.

Ibrahim-Zada I, Ernest P, Moore EE. Ibrahim-Zada I, et al. J Trauma Acute Care Surg. 2018 Sep;85(3):644-645. doi: 10.1097/TA.0000000000001958. J Trauma Acute Care Surg. 2018. PMID: 29787538 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters